Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SXTP

+ Watchlist+ Portfolio

60 Degrees Pharmaceuticals, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.54
52-Week Range
$0.46 – $8.62
Market Cap
$2.24M
P/E (TTM)
—
EPS (TTM)
-5.34
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
-327.36%
Return on Assets
-112.56%
Gross Margin
-50.27%
Operating Margin
-957.98%
Profit Margin
0.00%
Current Ratio
1.17
Debt/Equity
0.20
Total Debt
$150.40K
Free Cash Flow
$-5.66M
Revenue Growth
-55.90%
Earnings Growth
—
Enterprise Value
$10.69M

Market Snapshot

About

60 Degrees Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for the treatment and prevention of infectious diseases. The company is advancing tafenoquine, an 8-aminoquinoline antimalarial drug, for malaria prevention in travelers and military personnel. It leverages partnerships to develop and commercialize its product candidates.